Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals

被引：0
作者：
N. Tavassoli
E. Duchayne
B. Sadaba
K. Desboeuf
A. Sommet
M. Lapeyre-Mestre
M. J. Muoz
P. Sie
J. Honorato
J. L. Montastruc
H. Bagheri
机构：
[1] Université Paul Sabatier,Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi
[2] Faculté de Médecine,Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’informations sur le Médicament, Unité de Pharmacoépidémiologie EA 3696
[3] Hôpital Purpan,Laboratoire d’Hématologie, Centre Hospitalier Universitaire
[4] University Hospital of Navarra,Department of Clinical Pharmacology
[5] Centre Hospitalier Universitaire,Département d’information médicale
[6] Université Paul Sabatier,Service de Pharmacologie Clinique
[7] Faculté de Médecine,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Drug-induced agranulocytosis; Laboratory monitoring; Underreporting rate; Pharmacovigilance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database
    Yan, Liyuan
    Zheng, Guanqun
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 345 - 353
  • [42] Drug-induced tumoral disease: A global pharmacovigilance database analysis
    Zelmat, Yoann
    Despas, Fabien
    THERAPIE, 2024, 79 (02): : 189 - 197
  • [43] Drug-induced second tumors: a disproportionality analysis of the FAERS database
    Shupeng Chen
    Yuzhe Zhang
    Xiaojian Li
    Nana Tang
    Yingjian Zeng
    Discover Oncology, 16 (1)
  • [44] Drug-induced gastrointestinal disorders in surgical patients admitted to the University Hospital, Jena, Germany
    Hippius, M
    Hegenbart, U
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (08) : 406 - 410
  • [45] Drug-induced skin ulcers: A combined disproportionality analysis using data from Medline and VigiBase®
    Duron, D.
    Blaise, S.
    Cracowski, J. L.
    Roustit, M.
    Khouri, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 17 - 18
  • [46] Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study
    Douros, Antonios
    Bronder, Elisabeth
    Andersohn, Frank
    Klimpel, Andreas
    Thomae, Michael
    Sarganas, Giselle
    Kreutz, Reinhold
    Garbe, Edeltraut
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (06) : 988 - 999
  • [47] Drug-induced membranous nephropathy: Disproportionality analysis of the WHO safety database
    Gerard, A. O.
    Merino, D.
    Cremoni, M.
    Destere, A.
    Teisseyre, M.
    Esnault, V. L. M.
    Sicard, A.
    Seitz-Polski, B.
    Drici, M. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 62 - 63
  • [48] Risk of drug-induced pericardial effusion: a disproportionality analysis of the FAERS database
    Ren, Gaocan
    Huang, Pingping
    Ding, Yanqiu
    Ma, Xiaochang
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01)
  • [49] Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)
    Laroche, Marie-Laure
    Gautier, Sophie
    Polard, Elisabeth
    Rabier, Marie-Blanche
    Chouchana, Laurent
    Lebrun-Vignes, Benedicte
    Faillie, Jean-Luc
    Petitpain, Nadine
    Lagarce, Laurence
    Jonville-Bera, Annie-Pierre
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 390 - 400
  • [50] Drug-induced radiation recall reactions and non-anticancer drugs: A descriptive analysis from VigiBase®
    Aubin-Beale, Eyrian
    Giorgi, Lorene
    Beurrier, Mathilde
    Granel-Brocard, Florence
    Gillet, Pierre
    Fresse, Audrey
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 (03) : 673 - 679
12345